PETER GOBAR: Open Payments
NPI 1164408761 · ATLANTIS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,145 in 45 payments from 14 companies in 2025. Trend: 2023 $788 · 2024 $1,274 · 2025 $1,145
Food & beverage: $1,145
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 10 | $165 |
| ABBVIE INC. | 6 | $142 |
| LivaNova USA, Inc. | 2 | $139 |
| Janssen Pharmaceuticals, Inc | 5 | $135 |
| Vanda Pharmaceuticals Inc. | 4 | $119 |
| Axsome Therapeutics, Inc. | 4 | $113 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $85 |
| Alkermes, Inc. | 3 | $67 |
| E.R. Squibb & Sons, L.L.C. | 2 | $56 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
Products named: Azstarys, VRAYLAR, VNS THERAPY SYMMETRY MODEL 8103 GENERATOR, FANAPT, SPRAVATO, Auvelity, CAPLYTA, REXULTI.
Industry payments across FL — which companies pay providers there.
